HairCapillus is committed to helping women and men fighting breast cancer. The Capillus caps use Low Level Laser Therapy technology (LLLT), a medical treatment for hair loss that is both minimally invasive and chemical-free. LLLT treats a myriad of issues, including androgenetic alopecia—more commonly known as male or female-pattern baldness.
Physicians sometimes recommend Capillus laser caps to patients who are seeking hair restoration post medically-induced hair loss from chemotherapy. Individuals are advised to consult with their doctor or physician about using Capillus for anything other than its intended purpose as it is only cleared for use by the FDA for the treatment of hereditary hair loss.
Capillus will donate 3% of sales from any of the Capillus laser therapy cap (Capillus82™, Capillus202™, Capillus272™, and CapillusRX™) devices that are purchased from http://www.capillus.com to breast cancer research throughout the month of October.
Click here to download full press release.